Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Haemonetics
HAE
$4.93B
| $13.8M | 0.02% |
306,824
-68,124
| -18% | -$2.83M |
|
1027
Progress Software
PRGS
$1.78B
| $13.8M | 0.02% |
360,449
-270,758
| -43% | -$9.05M |
|
|
CBAY
1028
DELISTED
Cymabay Therapeutics
CBAY
| $13.7M | 0.02% |
1,703,124
+1,277,226
| +300% | +$8.64M |
|
1029
Element Solutions
ESI
$8.52B
| $13.7M | 0.02% |
1,228,291
+674,493
| +122% | +$8.35M |
|
1030
Skyworks Solutions
SWKS
$10.1B
| $13.7M | 0.02% |
134,149
+64,386
| +92% | +$6.68M |
|
1031
Jefferies Financial Group
JEF
$12B
| $13.7M | 0.02% |
604,449
-428,013
| -41% | -$9.59M |
|
1032
Invesco Mortgage Capital
IVR
$805M
| $13.7M | 0.02% |
79,703
+23,968
| +43% | +$4.04M |
|
1033
Travere Therapeutics
TVTX
$6.15B
| $13.6M | 0.02% |
548,334
+260,236
| +90% | +$5.73M |
|
1034
CALL
Albemarle
ALB
$16.7B
| $13.6M | 0.02% |
+100,000
| New | +$11.9M |
|
|
ULTI
1035
DELISTED
Ultimate Software Group Inc
ULTI
| $13.6M | 0.02% |
71,657
+23,779
| +50% | +$4.8M |
|
1036
News Corp Class A
NWSA
$16.6B
| $13.6M | 0.02% |
1,024,196
+707,194
| +223% | +$9.57M |
|
1037
CALL
XPO
XPO
$22.5B
| $13.6M | 0.02% |
578,279
| – | – |
|
1038
AAR Corp
AIR
$5.42B
| $13.5M | 0.02% |
358,200
+282,727
| +375% | +$10.2M |
|
1039
St. Joe Company
JOE
$3.99B
| $13.5M | 0.02% |
716,800
+702,831
| +5,031% | +$13.1M |
|
|
CQH
1040
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $13.5M | 0.02% |
538,765
+100,005
| +23% | +$2.56M |
|
1041
Brown & Brown
BRO
$25B
| $13.5M | 0.02% |
+558,548
| New | +$12.5M |
|
|
TCF
1042
DELISTED
TCF Financial Corporation Common Stock
TCF
| $13.4M | 0.02% |
257,376
-120,621
| -32% | -$5.76M |
|
|
RAVN
1043
DELISTED
Raven Industries Inc
RAVN
| $13.4M | 0.02% |
414,235
+93,561
| +29% | +$3.02M |
|
|
ESL
1044
DELISTED
Esterline Technologies
ESL
| $13.4M | 0.02% |
148,800
+127,815
| +609% | +$11.5M |
|
|
XLRN
1045
DELISTED
Acceleron Pharma
XLRN
| $13.4M | 0.02% |
359,304
-184,174
| -34% | -$6.39M |
|
1046
UFP Industries
UFPI
$4.92B
| $13.4M | 0.02% |
408,192
-86,253
| -17% | -$2.49M |
|
1047
Cullen/Frost Bankers
CFR
$10.2B
| $13.3M | 0.02% |
140,399
-101,240
| -42% | -$9.15M |
|
|
ITG
1048
DELISTED
Investment Technology Group Inc
ITG
| $13.3M | 0.02% |
601,878
-58,163
| -9% | -$1.22M |
|
1049
Hanover Insurance
THG
$7.92B
| $13.3M | 0.02% |
137,445
-404,049
| -75% | -$38.4M |
|
|
SPLK
1050
CALL
DELISTED
Splunk Inc
SPLK
| $13.3M | 0.02% |
+200,000
| New | +$12.5M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.